Margaret G. McGlynn

Companies

• NovavaxBoard member Dec 9, 2020 to now¹
• Amicus TherapeuticsBoard member Nov 6, 2009 to now²
• Vertex PharmaceuticalsBoard member May 13, 2011 to May 3, 2023³
• Air Products & ChemicalsBoard member Mar 17, 2005 to Oct 1, 2020⁴
• MERCK SHARP & DOHME LLCPresident Mar 7, 2006 to Apr 27, 2009⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Novavax NVAX44,468 shares⁶$481.1K at $10.82Jun 20, 2026
• Vertex Pharmaceuticals VRTX178 shares⁷$93.5K at $525.12May 1, 2022
• Amicus Therapeutics FOLD0 shares⁸Apr 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 20, 2026Exercised options 18,880 shares of Novavax⁶
• Apr 27, 2026Returned to company 94,631 shares at $14.50 of Amicus Therapeutics⁸
• Jun 12, 2025Exercised options 10,420 shares of Novavax⁹
• Jun 5, 2025Granted 20,414 shares of Amicus Therapeutics¹⁰
• Dec 31, 2024Granted 1,178 shares at $8.61 of Novavax¹¹
• Sep 30, 2024Granted 778 shares at $12.77 of Novavax¹¹
• Jun 30, 2024Granted 713 shares at $13.93 of Novavax¹¹
• Jun 12, 2024Exercised options 6,670 shares of Novavax¹²
• Jun 6, 2024Granted 11,847 shares of Amicus Therapeutics¹³
• Mar 31, 2024Granted 2,029 shares at $4.90 of Novavax¹¹
• Mar 5, 2024Sold 7,500 shares at $13.40 of Amicus Therapeutics¹⁴
• Mar 5, 2024Exercised options 7,500 shares at $2.80 of Amicus Therapeutics¹⁴
• Mar 4, 2024Sold 7,500 shares at $13.29 of Amicus Therapeutics¹⁴
• Mar 4, 2024Exercised options 7,500 shares at $2.80 of Amicus Therapeutics¹⁴
• Jun 10, 2023Exercised options 3,100 shares of Novavax¹⁵
• Jun 8, 2023Granted 8,584 shares of Amicus Therapeutics¹⁶
• Jan 13, 2023Sold 15,000 shares at $13.03 of Amicus Therapeutics¹⁷
• Jan 13, 2023Exercised options 15,000 shares at $3.32 of Amicus Therapeutics¹⁷
• Jun 17, 2022Exercised options 700 shares of Novavax¹⁸
• Jun 9, 2022Granted 12,671 shares of Amicus Therapeutics¹⁹
• May 2, 2022Sold 15,000 shares at $6.99 of Amicus Therapeutics²⁰
• May 2, 2022Exercised options 15,000 shares at $4.79 of Amicus Therapeutics²⁰
• May 1, 2022Returned to company 921 shares of Vertex Pharmaceuticals⁷
• Apr 8, 2022Sold 100 shares at $281.49 of Vertex Pharmaceuticals²¹
• Apr 8, 2022Sold 4,900 shares at $280.19 of Vertex Pharmaceuticals²¹